Pure Biologics S.A.

Equities

PUR

PLPRBLG00010

Biotechnology & Medical Research

Delayed Warsaw S.E. Other stock markets 14:12:08 14/05/2024 BST			5-day change	1st Jan Change
7.62 ^PLN	+4.38%		+2.97%	-39.72%

2023	Pure Biologics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Pure Biologics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Pure Biologics Spólka Akcyjna announced that it has received PLN 10.1 million in funding

April 23, 2019

Pure Biologics Spólka Akcyjna (WSE:PUR) announced that it has received PLN 10.1 million in a round of funding on April 24, 2019. The company has issued 481,590 common shares at a price of PLN 20.972196 per common share.

Latest news about Pure Biologics S.A.

Pure Biologics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-15	CI
Pure Biologics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
Presage Announces Collaboration with Pure Biologics to Investigate Oncology Agents in Early Development with CIVO® Technology	06/02/23	CI
Dom Maklerski Navigator S.A. and IPOPEMA Securities S.A. agreed to acquire an unknown minority stake in Pure Biologics Spólka Akcyjna.	12/12/22	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/11/22	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2022	16/09/22	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22	CI
Pure Biologics Sp?lka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2021	10/09/21	CI
Pure Biologics Spólka Akcyjna announced that it has received €6.7 million in funding from National Centre for Research and Development	20/08/19	CI
Pure Biologics Spólka Akcyjna announced that it has received PLN 10.1 million in funding	23/04/19	CI

Chart Pure Biologics S.A.

Duration

Period

More charts

Company Profile

Pure Biologics SA is a manufacturer of biological products. The Company was founded in August 2010 and is located in Wroclaw, Poland.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
PURE BIOLOGICS S.A.	-39.72%	6.12M
MODERNA, INC.	+29.29%	48.16B
IQVIA HOLDINGS INC.	-0.71%	41.73B
LONZA GROUP AG	+43.85%	41.03B
CELLTRION, INC.	-5.31%	28.77B
ICON PUBLIC LIMITED COMPANY	+10.60%	25.59B
ALNYLAM PHARMACEUTICALS, INC.	-21.70%	18.96B
BIO-TECHNE CORPORATION	+8.11%	12.92B
MEDPACE HOLDINGS, INC.	+26.74%	12.03B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.13%	11.77B

Other Biotechnology & Medical Research